Investor 5AM Ventures V, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by 5AM Ventures V, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2022-12-02 13D/A AKUS / Akouos Inc 4,135,784 0
2022-08-03 13D/A CABA / Cabaletta Bio, Inc. 2,064,263 1,030,318
2022-06-07 13D/A RLYB / Rallybio Corporation 4,190,724 3,747,531
2021-11-12 13D TRDA / Entrada Therapeutics, Inc. 4,409,687
2021-11-03 13D/A CABA / Cabaletta Bio, Inc. 2,359,263 2,064,263
2021-09-09 13D/A CABA / Cabaletta Bio, Inc. 2,984,263 2,359,263
2021-08-12 13D RLYB / Rallybio Corporation 4,190,724
2021-05-07 13G IMPL / Impel Pharmaceuticals Inc. 2,884,791
2021-01-12 13D/A CABA / Cabaletta Bio, Inc. 3,371,263 2,984,263
2020-12-31 13D/A AKUS / Akouos Inc 4,135,784
2020-12-14 13D/A CABA / Cabaletta Bio, Inc. 4,605,784 3,371,263
2020-07-10 13D CABA / Cabaletta Bio, Inc. 3,669,266 4,605,784
2019-11-12 13D CABA / Cabaletta Bio, Inc. 3,669,266